David Horák

ORCID: 0000-0001-5766-202X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Imaging and Diagnostics
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Coronary Interventions and Diagnostics
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Congenital Diaphragmatic Hernia Studies
  • Tracheal and airway disorders
  • Lipoproteins and Cardiovascular Health
  • Vascular Procedures and Complications
  • Cardiac Structural Anomalies and Repair
  • Lung Cancer Diagnosis and Treatment
  • Cardiovascular and exercise physiology
  • Management of metastatic bone disease
  • Vascular anomalies and interventions
  • Heart Rate Variability and Autonomic Control
  • Childhood Cancer Survivors' Quality of Life
  • Respiratory Support and Mechanisms
  • Vascular Anomalies and Treatments
  • Sinusitis and nasal conditions
  • Vascular Malformations Diagnosis and Treatment
  • Cardiac Fibrosis and Remodeling
  • Pleural and Pulmonary Diseases
  • Diabetes, Cardiovascular Risks, and Lipoproteins

Johns Hopkins University
2017

Krajská Nemocnice Liberec
2008-2015

City of Hope
2015

University of Alabama at Birmingham
2015

City Of Hope National Medical Center
1987-2007

Cedars-Sinai Medical Center
1983

TOTAL (N = 10 732), a randomized trial of routine manual thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction, showed no difference the primary efficacy outcome but significant increase stroke. We sought to understand these findings. A detailed analysis stroke timing, severity, and subtype was performed. Strokes were adjudicated by neurologists blinded treatment assignment. Stroke within 30 days, safety outcome, increased [33 (0.7%) 16 (0.3%),...

10.1093/eurheartj/ehv296 article EN European Heart Journal 2015-06-29

This study was undertaken to determine the magnitude of pulmonary dysfunction in childhood cancer survivors when compared with healthy controls and extent (and predictors) decline over time.

10.1200/jco.2014.59.8318 article EN Journal of Clinical Oncology 2015-04-07
Roger D. Yusen Gerard J. Criner Jürgen Floege David H. Au Anne L. Fuhlbrigge and 95 more Richard Albert Richard Casaburi James K. Stoller Kathy Harrington John A. Cooper Philip Diaz Steven Gay Richard E. Kanner Neil MacIntyre Fernando J. Martínez Steven Piantadosi Frank C. Sciurba David Shade Thomas Stibolt James Tonascia Robert A. Wise William C. Bailey William C. Bailey Anne L. Fuhlbrigge Ernestina Sampong Karin Sloan Ashley L. Wagner Susan E. Anderson Marilyn L. Moy Osarenoma Okunbor James K. Stoller Scott Marlow Yvonne Meli R. C. Rice Loutfi S. Aboussouan Robert Castele Joseph G. Parambil Sumita Khatri Aman Pande Joe Zein Thomas Olbrych Stephan A. Alkins Christine Jocko Franck Rahaghi J. Barton Richard Albert Jennifer Underwood Barry J. Make Jennifer Underwood Neil MacIntyre John A. Davies Thomas Stibolt Richard A. Mularski Allison L. Naleway Sarah Vertrees Richard Casaburi János Pórszász Peggy Walker Renee Love Indelicato Lennard Specht Kathleen Ellstrom J. M. Portillo David Horák Brian Tiep Mary Barnett Philip Diaz Janice Drake Mahasti Rittinger Rachael Compton Scott Miller Ralph J. Panos Laura A. Lach Gerard J. Criner Carla Grabianowski Francis Cordova Parag Desai Samuel L. Krachman James Mamary Nathaniel Marchetti Aditi Satti Eileen Mumm Michelle Vega‐Olivo Jenny Hua Vanna Tauch Lii-Yoong H. Criner Michael E. Jacobs Peter Rising Paul Simonelli Michele Follen Mitchell Matthew R. Lammi Connie Romaine Howard Lee Mary Ianacone Steven M. Scharf Wanda Bell-Farrell M. Jeffery Mador Ayesha Rahman Mumtaz U. Zaman Lisa Hill Alec B. Platt

Section:ChooseTop of pageAbstract <<Background and Scientific...Original Study Design and...Final DesignStudy Entities Collab...SettingPatients EligibilityData CollectionScreeningRandomizationPostrandomization Visits ...InterventionsAdherence AssessmentOutcome AssessmentSample Size PowerStatistical MonitoringQuality AssuranceDiscussionReferencesCITING ARTICLES

10.1513/annalsats.201705-374sd article EN Annals of the American Thoracic Society 2017-10-31

Standard formulas for predicting postoperative forced expiratory volume in 1 second (po-FEV1) do not consider bronchi obstructed by tumor or chronic obstructive pulmonary disease, e.g., Formula [ppo-FEV1 = (pre-opFEV,) x (# segments remaining)/(# of total segments)] whereas 2 unobstructed does. A retrospective chart review was conducted to determine accuracy po-FEV1, at a comprehensive cancer center. Predicted po-FEV, calculated using different and analyzed regression analysis Pearson...

10.1177/000313480707301028 article EN The American Surgeon 2007-10-01

V letech 2007 a 2008 byla publikována nová doporučení pro diagnostiku léčbu akutních koronárních syndromů bez elevací ST. Článek se zabývá novými některými poněkud opomíjenými aspekty těchto doporučení. Nová kladou důraz na prevenci krvácivých komplikací vyvážení léčby z hlediska prospěchu ischemie/krvácení. K optimalizaci terapie jsou užívány metody rizikové stratifikace zmíněna i někdy opomíjená riziková skóre.

10.33678/cor.2009.222 article CS Cor et Vasa 2009-12-01
Coming Soon ...